Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2- breast cancer: A phase 1b/2 trial.
Gong C, Lin Q, Qin T, Zeng Y, Xu F, Yang Y, Yin D, Duan Z, Chen CL, Wing-Cheong Chow L, Liu Q, Hamaï A, Mehrpour M, Lin Q, Li J, Song E.
Gong C, et al. Among authors: liu q.
Med. 2024 Dec 23:100559. doi: 10.1016/j.medj.2024.11.012. Online ahead of print.
Med. 2024.
PMID: 39731909